Latest News

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Cancer-targeting mechanism under development

  • Stop blaming the moon: Intelligent people can develop strong entirely incorrect beliefs

  • Wearable technology can help with public speaking

  • Intelligent neuroprostheses mimic natural motor control

  • 'Wikipedia' for neurons created

  • Mother's diet influences weight-control neurocircuits in offspring

  • Rate of opioid misuse is around 25 percent, addiction rate 10 percent, reports study

  • Prototype 'nanoneedles' generate new blood vessels in mice, paving way for new regenerative medicine

  • Component of red grapes, wine could help ease depression

  • Crowdsourced tool for depression

  •